Hospice News February 25, 2025
In the final days of the Biden administration the U.S. Drug Enforcement Administration (DEA) proposed a rule that could change the game for prescribing controlled substances via telehealth, including some common hospice medications.
If finalized, this proposed rule would require prescribers to register with the DEA before they are allowed to prescribe schedule III-V controlled substances, along with some monitoring and other requirements.
“DEA’s goal is to provide telehealth access for needed medications while ensuring patient safety and preventing the diversion of medications into the illicit drug market,” said former DEA Administrator Anne Milgram, in a statement. “We understand the difficulties some patients have accessing medical providers in-person, and we want to ease this burden while also providing safeguards...
Today's Sponsors
Today's Sponsor